SL22108: Specialised integrated unit 4: special patient groups and surgery
[Page last updated: 26 October 2023]
| Academic Year: | 2023/24 |
| Owning Department/School: | Department of Life Sciences |
| Credits: | 10 [equivalent to 20 CATS credits] |
| Notional Study Hours: | 200 |
| Level: | Intermediate (FHEQ level 5) |
| Period: |
|
| Assessment Summary: | CWSG 15%, CWSI 15%, EXCB 70% |
| Assessment Detail: |
|
| Supplementary Assessment: |
|
| Requisites: | |
| Learning Outcomes: |
By the end of the unit, you will be able to:
1. Explain the effect that physiological and developmental changes have on the handling (including ADME) of medicines and on the pharmacological responses in special patient groups.
2. Describe the key aspects of disease monitoring in special patient groups.
3. Explain the disease and patient factors that are influenced before, during and after surgery.
4. Evaluate the evidence base for management of pre, peri and post- operative care.
5. Explain the use of unlicensed and licensed medicines off-label in each of the special patient groups.
6. Evaluate the medicines management issues in each of these patient groups.
7. Identify and evaluate evidence-based approaches for the management of special patient groups and patients undergoing surgery.
8. Describe the role of the pharmacist in prescribing, administering and monitoring medication for special patient groups and those undergoing a surgical procedure.
9. Make appropriate clinical decisions in support of prescribing for special patient groups.
10. Apply complex structured consultation skills to the conditions studied in this unit. |
| Synopsis: | This unit will provide you with a comprehensive, integrated understanding of the design and development of medicines, their pharmacological actions in the body and the evidence-based approach to treatment of, and promoting safe and effective outcomes in, special patient groups including pregnant and breast-feeding women, premature infants and paediatrics, the elderly, obese, those with renal impairment, and patients undergoing surgery. |
| Content: | Clinical introduction and overview of therapeutic area
Dose adjustment in special groups
Pharmacokinetics and pharmacodynamics in special patient groups
Age (paediatric and elderly) appropriate formulations
Enteral and Parenteral nutrition
Drug design and drug synthesis - short lecture series
Licensing and unlicensed use of medicines
Renal Pathology
Acute kidney injury and chronic kidney disease
Dialysis
Physiology of pregnancy, child birth and lactation
Drugs in pregnancy and breastfeeding. Drug distribution across placenta and to breastmilk
Treatment of pre-eclampsia
Prescribing for neonates and paediatrics including dose adjustment and calculations
Common childhood diseases including metabolic syndromes
Prescribing for, and pharmaceutical care of, the elderly
Medicines in surgery (pre, peri and post-op)
Anaesthetics - local, general and neuromuscular blockers
Imaging, x-rays, MRI and PET scanning, contrast media
Clinical decision-making in special patient groups
Simulation and practice-based learning in special patient groups |
| Course availability: |
SL22108 is a Must Pass Unit on the following courses:Department of Life Sciences
|
Notes:
|